Walsh, Zach
Mitchell, Ian
Crosby, Kim
St. Pierre, Michelle
DeClerck, Drew
Ong, Kaye
Lucas, Philippe
Funding for this research was provided by:
Tilray
Article History
Received: 25 April 2023
Accepted: 23 July 2023
First Online: 9 September 2023
Declarations
:
: This trial was registered on ClinicalTrials.gov (NCT02517424) and approved by the Clinical Research Ethics Board at the University of British Columbia (H16-01026). Participants provided written informed consent prior to participating.
: Not applicable.
: Philippe Lucas was Vice President, Global Patient Research and Access, for Tilray, the study sponsor, during the course of the clinical trial, and his compensation included stock options for Tilray.Zach Walsh has received research support from Tilray to conduct this study and has also received research support from DOJA who are a licensed producer of cannabis. Dr Walsh is a former Director of Indigenous Bloom which is a company that works to provide opportunities to Indigenous communities in Canada to engage in cannabis cultivation and sales.Kim Crosby, Michelle St. Pierre, and Drew DeClerck received paid research assistantships from MITACS and Tilray to assist with the implementation of the study.